FDAnews
www.fdanews.com/articles/176583-senseonics-gains-ce-mark-for-eversense-cgm-system

Senseonics Gains CE Mark for Eversense CGM System

May 11, 2016

Senseonics has garnered a CE Mark for its continuous Eversense continuous glucose monitoring system, the Germantown, Md.-based company announced Tuesday.

The implantable device features a transmitter for measuring glucose levels and an app to showcase glucose readings in real-time.

The system, which touts an implanted glucose sensor that can last up to 90 days, removes the need for a weekly sensor insertion used by traditional CGM systems. — Anisa Jibrell

 

View More Stories